Christopher Bradley, DO
Clinical Cardiac Electrophysiology · Southfield, MINPI 1659636140
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (51.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medtronic at 57.3% of the total. Reporting peaked in 2019 at $34,991 and has fallen 93.3% since, to $2,359 in 2025.
Across 239 payments — averaging $210.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$29K
- Abbott$14K
- Boston Scientific$6K
- Amgen$374
- Philips North America LLC$292
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$220
- plus $1K from 17 others
What the payments were for
- Consulting fees$3001%
- Grants$25,90151%
- Travel & lodging$11,86724%
- Food & beverage$12,31724%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 44 | $28,866 |
| Abbott | 122 | $13,908 |
| Boston Scientific | 25 | $5,649 |
| Amgen | 4 | $374 |
| Philips North America LLC | 3 | $292 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $220 |
| Kestra Medical Technology Services, Inc. | 2 | $154 |
| Penumbra, Inc. | 1 | $134 |
| AstraZeneca | 1 | $126 |
| Johnson & Johnson | 1 | $125 |
| Pfizer | 6 | $104 |
| Truvic Medical, Inc. | 1 | $100 |
| Biosense Webster, Inc. | 1 | $70 |
| Novartis | 3 | $54 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Impulse Dynamics (USA) Inc. | 1 | $31 |
| Edwards Lifesciences | 1 | $27 |
| Elutia, Inc. | 1 | $23 |
| Cordis US CORP. | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Altathera Pharmaceuticals LLC | 1 | $16 |
| Chiesi USA, Inc. | 1 | $15 |
| EKOS Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$3,985
- GENERAL - THERAPIES$3,143
- ENSITE PRECISION$1,933
- Ensite Cardiac Mapping System$1,774
- ENSITE$1,204
- Watchman$1,016
- GENERAL TACHY$901
- Repatha$362
- EnSite Precision Cardiac Mapping System$300
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$289
- Arctic Front$281
- GALLANT$265
- (9520) IGT Devices Undivided$265
- Fortify Assura, Ellipse ICD$222
- AGILIS$170
- Farapulse$149
- Optis Coronary Imaging System$149
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$147
- Accent Pacemaker$141
- Penumbra System$134
How this compares
$50,385 in reported general payments places this provider in the 75th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
See all clinical cardiac electrophysiology providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 249 | $259,861 |
| XareltoRivaroxaban | 55 | $66,529 |
| EntrestoSacubitril/Valsartan | 15 | $27,855 |
| Metoprolol Succinate | 208 | $4,097 |
| Flecainide Acetate | 41 | $2,601 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 31 | $1,344 |
| Amiodarone Hcl | 35 | $1,259 |
| Carvedilol | 71 | $882 |
| Losartan Potassium | 78 | $844 |
| Omeprazole | 50 | $644 |
| Atorvastatin Calcium | 43 | $473 |
| Bumetanide | 15 | $471 |
| Lisinopril | 28 | $316 |
| Furosemide | 50 | $297 |
| Amlodipine Besylate | 23 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $104 | $259,861249 claims |
| Johnson & JohnsonXarelto | $125 | $66,52955 claims |
| NovartisEntresto | $54 | $27,85515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
Other clinical cardiac electrophysiology in Southfield
- Dipak ShahSouthfield$194K
- Christian MachadoSouthfield$25K
- Randy LiebermanDetroit$1.2M
- Asim YunusSaginaw$236K
- Jackson LiangAnn Arbor$229K
- Ryan CunnaneAnn Arbor$218K
- Rakesh LatchamsettyBrighton$165K
- Ilana KutinskyTroy$138K
- Nishaki MehtaRoyal Oak$133K
- Andre GauriGrand Rapids$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.